SRSF10
Serine/arginine-rich splicing factor 10
You are using an outdated browser. Please upgrade your browser to improve your experience.
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
interacting protein | 0.93 | ||
virus perturbation | 0.9 | ||
transcription factor binding site profile | 0.87 | ||
ligand (protein) perturbation | 0.83 | ||
microRNA | 0.8 | ||
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
- OR - satisfy the following criterion:
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Target has at least one approved drug - AND - satisfies the preceding conditions
Click on a row in the table to change the structure displayed.
Data Source | Name | Explore in Pharos | Explore in Source | ||
---|---|---|---|---|---|
Reactome | Metabolism of RNA | ||||
Reactome | Processing of Capped Intron-Containing Pre-mRNA | ||||
Reactome | mRNA Splicing | ||||
Reactome | mRNA Splicing - Major Pathway | ||||
Name | Explore in Pharos | Explore in Source | ||
---|---|---|---|---|
Metabolism of RNA | ||||
Processing of Capped Intron-Containing Pre-mRNA | ||||
mRNA Splicing | ||||
mRNA Splicing - Major Pathway | ||||
GO Term | Evidence | Assigned by | ||
---|---|---|---|---|
Inferred from Direct Assay (IDA) | UniProtKB | |||
Non-traceable Author Statement (NAS) | UniProtKB | |||
Non-traceable Author Statement (NAS) | UniProtKB | |||
GWAS Trait | EFO ID | Study Count | SNP Count | Beta Count | Odds Ratio | Evidence (Mean Rank Score) | Provenance | ||
---|---|---|---|---|---|---|---|---|---|
eosinophil count | 3 | 3 | 3 | 91.9 | |||||
eosinophil percentage of leukocytes | 2 | 2 | 2 | 85.5 | |||||
lymphocyte count | 1 | 1 | 1 | 59 | |||||
eosinophil percentage of granulocytes | 1 | 1 | 1 | 35 | |||||
red blood cell distribution width | 1 | 1 | 1 | 17.4 | |||||
GWAS Trait | EFO ID | Beta Count | Odds Ratio | Evidence (Mean Rank Score) | Provenance | ||
---|---|---|---|---|---|---|---|
eosinophil count | 3 | 91.9 | |||||
eosinophil percentage of leukocytes | 2 | 85.5 | |||||
lymphocyte count | 1 | 59 | |||||
eosinophil percentage of granulocytes | 1 | 35 | |||||
red blood cell distribution width | 1 | 17.4 | |||||
Species | Name | Source ID | Gene ID | OMA | EggNOG | Inparanoid | ||
---|---|---|---|---|---|---|---|---|
Macaque | serine/arginine-rich splicing factor 10 | 705832 | ||||||
Mouse | MGI:1333805 | 14105 | ||||||
Rat | RGD:1311067 | 362630 | ||||||
Horse | serine and arginine rich splicing factor 10 [Source:HGNC Symbol;Acc:HGNC:16713] | |||||||
Xenopus | serine/arginine-rich splicing factor 10 | XB-GENE-492982 | 496509 | |||||
Species | Name | OMA | EggNOG | Inparanoid | ||
---|---|---|---|---|---|---|
Macaque | serine/arginine-rich splicing factor 10 | |||||
Mouse | ||||||
Rat | ||||||
Horse | serine and arginine rich splicing factor 10 [Source:HGNC Symbol;Acc:HGNC:16713] | |||||
Xenopus | serine/arginine-rich splicing factor 10 | |||||
PMID | Year | Title |
---|